Skip to main content
Premium Trial:

Request an Annual Quote

BioMérieux Adds Life Tech PCR Instruments to Molecular Biology Workflow

NEW YORK (GenomeWeb News) — BioMérieux said today that it has signed a strategic agreement with Life Technologies to integrate Life Tech's 7500 range of thermocyclers into its molecular biology workflow for reference or centralized laboratory customers.

Specifically, BioMérieux will integrate Life Tech's ABI 7500, 7500 Fast, and 7500 Fast Dx instruments with its own NucliSens EasyMag sample purification platform and soon-to-be-launched EasyStream liquid handling system for PCR setup. BioMérieux said that it will offer its NucliSentral middleware to connect the platforms.

The combined offering, the company said, will enable centralized or reference labs to optimize testing flow by batches, to add standardization and traceability to further improve quality of results, and to add new modules and gradually invest according to their needs.

Further, users will be able to use their own laboratory-developed tests and perform custom multiplexed panels on the modular system. Most BioMérieux PCR assays, particularly for infectious diseases, are already validated on the ABI 7500 instruments, the company said.

"Our molecular biology solution will bring to our customers enhanced automation and unparalleled flexibility for improved care of patients in the field of infectious disease diagnostics," Alexandre Mérieux, corporate vice president of BioMérieux's microbiology and molecular biology unit, said in a statement.

Financial terms of the agreement were not disclosed.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.